Sputtr.com | Alternative Search Engine

Actos

advantage® program

SAVE up to $50 00 * advantage ® program ACTOS FAMILY PRODUCT REBATE OFFER *You must meet eligibility requirements. Rebate Offer Expires 12/31/11 (Please print) Name: Address: City: State: ZIP: Amount Paid: $ Email: Your signature on this rebate certifies that you are not covered by the Medicare ...

program A C T O S F A M I L Y PR O D U C T RE B A T E O ...

SAVE up to $50 00 * advantage ® program ACTOS FAMILY PRODUCT REBATE OFFER *You must meet eligibility requirements. Rebate Offer Expires 3/31/12 (Please print)

Actos medication guide

MEDICATION GUIDE ACTOS ® (ak-TŌS)* (pioglitazone hydrochloride) tablets* Read this Medication Guide carefully before you start taking ACTOS and each time you get a refill.

ACTOS (pioglitazone hydrochloride) Tablets, Takeda Global ...

Page 1of 43 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ACTOS safely and effectively.

Patient Information About ACTOS® (pioglitazone HCl) Tablets ...

Patient Information About ACTOS ® (pioglitazone HCl) Tablets: 15 mg, 30 mg, and 45 mg. What is ACTOS? ACTOS is a clinically proven, once-a-day medicine that belongs to a class of prescription oral diabetes drugs called thiazolidinediones.

What is in this leaflet

ACTOS ® pioglitazone hydrochloride Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about ACTOS. It does not contain all the available information and does not take the place of talking with your doctor or pharmacist.

ACTOS™

ACTOS™ (Pioglitazone Hydrochloride) Tablets NDA No. 21-073 Version: 21073LBL.DOC Page 1 ACTOS™ (Pioglitazone Hydrochloride) Tablets DESCRIPTION ACTOS (pioglitazone hydrochloride) is an oral antidiabetic agent that acts primarily by decreasing insulin resistance.

Initial REMS Approval: 09/2009 Most Recent Modification: 08/2011

Initial REMS Approval: 09/2009 Most Recent Modification: 08/2011 NDA 21-073 ACTOS (pioglitazone hydrochloride) tablets A thiazolidinedione agonist for peroxisome proliferator-activated receptor gamma* Takeda Global Research & Development Center, Inc.One Takeda Parkway*

EPAR summary for the public - Actos

7 Westferry Circus ● Canary Wharf ● London E14 4HB ● United Kingdom Telephone +44 (0)20 7418 8400 Facsimile +44 (0)20 7418 8416 E-mail info@ema.europa.eu Website www.ema.europa.eu

GIRARD GIBBS LLP FILES A FEDERAL LAWSUIT AGAINST THE MAKERS ...

FOR IMMEDIATE RELEASE AUGUST 22, 2011 CONTACT: ERIC GIBBS PHONE: 415.981.4800 GIRARD GIBBS LLP FILES A FEDERAL LAWSUIT AGAINST THE MAKERS OF ACTOS SAN FRANCISCO, CA - Girard Gibbs LLP ( www.GirardGibbs. com ) filed a federal lawsuit against Takeda Pharmaceuticals and Eli Lilly and Company ...